Blood uric acid levels in patients with sleep-disordered breathing;Valores de ácido úrico en sangre en pacientes con trastornos respiratorios del sueño

Archivos de Bronconeumologia

Volumn 42, Issue 10, 2006, Pages 492-500

  Ruiz García, Aránzazu ^a,b   Sánchez Armengol, Ángeles ^a   Luque Crespo, Estefanía ^a   García Aguilar, Domingo ^a   Romero Falcón, Auxiliadora ^a   Carmona Bernal, Carmen ^a   Capote, Francisco ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b NONE   (Spain)

Author keywords

Diagnosis; Sleep apnea hypopnea syndrome; Uric acid

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID; XANTHINE;

ANAMNESIS; ARTICLE; BLOOD ANALYSIS; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; OXYGEN SATURATION; PATIENT MONITORING; POLYSOMNOGRAPHY; SLEEP APNEA SYNDROME; SLEEP DISORDERED BREATHING; TRIACYLGLYCEROL BLOOD LEVEL; UNIVARIATE ANALYSIS; URIC ACID BLOOD LEVEL;

EID: 33751026690     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1157/13093391     Document Type: Article

References (31)

1. Lin JD, Chiou WK, Weng HF, Fang JT, Liu TH. Application of three-dimensional body scanner: observation of prevalence of metabolic syndrome. Clin Nutr. 2004;23:1313-23.
2. Jubber AS. Respiratory complications of obesity. Int J Clin Pract. 2004;58:573-80.
3. Nieto F, Young T, Lind B. Association of sleep-disordered breathing, sleep apnea and hypertension in a large community-based study: Sleep Heart Health Study. JAMA. 2000;283:1829-36.
4. Peppard P, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342:1378-84.
5. Braghiroli A, Sacco C, Erbetta M, Ruga V, Dormer CF. Overnight urinary acid: creatinine ratio for detection of sleep hypoxemia. Validation study in chronic obstructive pulmonary disease and obstructive sleep apnea before and after treatment with nasal continuous positive airway pressure. Am Rev Respir Dis. 1993;148:173-8.
6. Hasday JD, Gram CM. Nocturnal increase of urinary uric acid: creatinine ratio. A biochemical correlate of sleep-associated hypoxemia. Am Rev Respir Dis. 1987;135:534-8.
7. Sahebjani H. Changes in urinary uric acid excretion in obstructive sleep apnea before and after therapy with nasal continuous positive airway pressure. Chest. 1998;113:1604-8.
8. McKeon JL, Saunders NA, Murree-Allen K, Olson LG, Gyulay S, Dickeson J, et al. Urinary uric acid: creatinine ratio, serum erythropoietin, and blood 2,3-diphosphoglycerate in patients with obstructive sleep apnea. Am Rev Respir Dis. 1990;142:8-13.
9. American Sleep Disorders Association. Sleep disorders atlas task force. EEG arousals: scoring rules and examples. Sleep. 1992; 15:173-84.
10. Leyva F, Anker SD, Godsland IF, Teixeira M, Hellewell PG, Kox WJ, et al. Uric acid in chronic heart failure: a marker of chronic inflammation. Eur Heart J. 1998;19:814-22.
11. Leyva F, Chua TP, Anker SD, Coats AJ. Uric acid in chronic heart failure: a measure of the anaerobic threshold. Metabolism. 1998; 47:1156-9.
12. Busquets X, Barbé F, Barceló A, De la Pena M, Sigritz N, Mayoralas LR, et al. Decreased plasma levels of orexin-A in sleep apnea. Respiration. 2004;71:575-9.
13. Barceló A, Barbé F, Llompart E, De la Pena M, Durán-Cantolla J, Ladaria A, et al. Neuropeptide Y and leptin in patients with obstructive sleep apnea syndrome: role of obesity. Am J Respir Crit Care Med. 2005;171:183-7.
14. Tatsumi K, Kasahara Y, Kurosu K, Tanabe N, Takiguchi Y, Kuriyama T. Sleep oxygen desaturation and circulating leptin in obstructive sleep apnea-hypopnea syndrome. Chest. 2005;127:716-21.
15. Durán J, Esnaola S, Ramon R, Iztueta A. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 years. Am J Respir Crit Care Med. 2001;163:608-13.
16. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med. 1999;131:7-13.
17. Kushida CA, Efron B, Guilleminault C. A predictive morphometric model for the obstructive sleep apnea syndrome. Ann Intern Med. 1997;127:581-7.
18. Rodenstein DO. Trastornos respiratorios con pulmón sano. En: Rodés Teixidor J, Guardia Massó J, editores. Medicina interna. Barcelona: Massó; 1997.
19. Nagahama K, Iseki K, Inoue T, Tourna T, Ikemiya Y, Takishita S. Hyperuricemia and cardiovascular risk factor clustering in a screened cohort in Okinawa, Japan. Hypertens Res. 2004;27: 227-33.
20. Corella D, Silla J, Ordovas JM, Sabater A, Ruiz de la Fuente S, Potoles O, et al. Asociación entre el ácido úrico sérico y otros factores de riesgo cardiovascular en población laboral masculina de Valencia. Rev Clin Esp. 1999;199:806-12.
21. Conen D, Wietlisbach V, Bovet P, Shamlaye C, Riesen W, Paccaud F, et al. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health. 2004;25:4-9.
22. Guilleminault C, Quera-Salva M, Partinen M, Jamieson A. Women and the obstructive sleep apnea syndrome. Chest. 1998;93: 104-9.
23. Quintana-Gallego E, Carmona-Bemal C, Capote F, Sánchez-Armengol A, Botebol-Benhamou G, Polo-Padillo J, et al. Gender differences in obstructive sleep apnea syndrome: a clinical study of 1166 patients. Respir Med. 2004;98:984-9.
24. Wallace KL, Riedel AA, Joseph-Ridge N, Wortmann R. Increasing prevalence of gout and hiperuricemia over 10 years among older adults in a managed care population. J Rheumatol. 2004;31: 1582-7.
25. Desai MY, Santos RD, Dalal D, Carvalho JA, Martin DR, Flynn JA, et al. Relation of serum uric acid with metabolic risk factors in asymptomatic middle-aged Brazilian men. Am J Cardiol. 2005; 9:865-8.
26. Young T, Palta M, Dempsey J, Weber S, Badr S. The occurrence of sleep disorders breathing among middle aged adults. N Engl J Med. 1993;328:1230-6.
27. Durán-Cantolla J, Mar J, De la Torre Muñecas G, Rubio Aramendi R, Guerra L. El síndrome de apneas-hipopneas durante el sueño en España. Disponibilidad de recursos para su diagnóstico y tratamiento en los hospitales del Estado español. Arch Bronconeumol. 2004;40:259-67.
28. Capote F, Masa JF, Jiménez A, Peces-Barba G, Amilibia J, Rubio R. Manifestaciones clinicas del SAHS. Métodos diagnósticos. Síndrome de resistencia aumentada de la vía aérea superior. Arch Bronconeumol. 2002;38 Supl 3:21-7.
29. Ross SD, Sheinhait IA, Harrison KJ, Kvasz M, Connelly JE, Shea SA, et al. Systematic review and meta-analysis of the literature regarding the diagnosis of sleep apnea. Sleep. 2000;23:519-32.
30. Barbé F, Amilibia J, Capote F, Durán J, Mangado N, Jiménez A, et al. Diagnóstico del síndrome de apneas obstructivas durante el sueño. Informe de consenso del Area de Insuficiencia Respiratoria y Trastornos del sueño. Arch Bronconeumol. 1995;31:460-2.
31. American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep. 1999;22:667-89.